Bristol-Myers Inks $440M Sales Deal With Reckitt Benckiser
Pharmaceutical giant Bristol-Myers Squibb Co. has signed off on a $438 million collaboration agreement giving British manufacturer Reckitt Benckiser Group PLC exclusive rights to sell several of the drugmaker's Latin American...To view the full article, register now.
Already a subscriber? Click here to view full article